Search

Silvia Escribano Serrat is a physician-scientist specializing in hematology working as a research fellow in the Shouval Lab. After graduating medical school at Universidad Autónoma de Madrid, Silvia completed her training in hematology and hemotherapy at Hospital Clínico San Carlos, where she was an active physician-scientist in the molecular biology laboratory.

… Job Title Visiting Investigator Silvia Escribano Serrat is a physician-scientist specializing in hematology working as a research fellow in the Shouval Lab. After graduating medical school at Universidad Autónoma de Madrid, Silvia completed her training in hematology and hemotherapy at Hospital Clínico

Antibody-drug conjugates and checkpoint inhibitors show promise as new therapies for bladder cancer.

… Monday, September 12, 2022 Promising new drugs have begun to transform the treatment of bladder (or urothelial) cancer, the sixth most common form of the disease in the U.S., and the fourth most common in men. In particular, two drug classes, antibody-drug conjugates (ADCs) and checkpoint inhibitors,

… Job Title Graduate Research Student Fellowship Bochner-Wachenheim Fellowship Email [email protected]

… Job Title Visiting Scientist—University of Toronto Degree PhD Email [email protected] Office Phone 646-888-3286

Glennis Mehra, PhD, is Director of the Entrepreneurship Initiative (EI) in the Office of Entrepreneurship & Commercialization.

… Job Title Director, Entrepreneurship Initiative Glennis Mehra, PhD, is Director of the Entrepreneurship Initiative (EI) within the Office of Entrepreneurship & Commercialization at Memorial Sloan Kettering Cancer Center, where she leads the development of a venture creation engine to translate oncology

Learn the most frequently asked questions about immunotherapy, a form of cancer treatment that uses the body's own immune system to overpower cancer cells. Learn who it can help, how it works, and how experts at MSK are finding ways to make it benefit more people, including new combinations with other cancer treatments like chemotherapy, surgery, radiation and more.

… Tuesday, November 7, 2023 Immunotherapy is one of the most promising approaches to cancer treatment . Unlike other forms of cancer treatment, in which drugs or radiation target cancer cells directly, immunotherapy targets your immune system, boosting its innate power to fight the cancer. But how does

… Full Title Randomized Pilot Study of Ruxolitinib for Switch-Maintenance Prophylaxis of Graft-versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation after Intermediate-Dose Post-Transplant Cyclophosphamide (Rux Switch-Maintenance in Intermediate PTCY: RuSMa-PTCY) in Comparison to Full-Dose

Postdoctoral Fellow, Memorial Sloan Kettering Cancer Center

… Job Title Postdoctoral Fellow, Memorial Sloan Kettering Cancer Center Fellowships Geoffrey Beene Graduate Student Fellowship (2019-2020) Ruth L. Kirschstein Predoctoral Individual National Research Service Fellowship, NIH National Cancer Institute (2021-2024) NCI Predoctoral to Postdoctoral Fellow Transition

This information will help you get ready for your HDR brachytherapy with interstitial implants for treatment of gynecologic cancer at MSK.

… This information will help you get ready for your HDR brachytherapy (BRAY-kee-THAYR-uh-pee) with interstitial (IN-ter-STIH-shul) implants for treatment of gynecological cancers at MSK. Read this resource at least once before your brachytherapy procedure. Use it as a reference in the days leading up to

Esta información la ayudará a prepararse para su braquiterapia HDR con implantes intersticiales para el tratamiento del cáncer ginecológico en MSK.

… Esta información la ayudará a prepararse para su braquiterapia HDR con implantes intersticiales para el tratamiento del cáncer ginecológico en MSK. Lea este recurso al menos una vez antes de su procedimiento de braquiterapia. Úselo como referencia en los días previos a su tratamiento. Tráigalo cada vez